Novel treatment approaches in combination with rituximab for immune tolerance induction in severe Hemophilia B

被引：0
|
作者：
Brandow, Amanda M. [1 ]
Punzalan, Rowena C. [1 ,2 ]
Stephany, Karen [2 ]
Hesell, Craig [2 ]
Gill, Joan C. [1 ,2 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Blood Ctr WI, Milwaukee, WI USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3975.3975
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3975
引用
收藏
页码：61B / 62B
页数：2
相关论文
共 50 条
  • [1] Successful treatment of immune tolerance induction with rituximab in a patient with severe hemophilia B and inhibitor
    Kobayashi, Ryoji
    Sano, Hirozumi
    Suzuki, Daisuke
    Kishimoto, Kenji
    Yasuda, Kazue
    Honjo, Ryota
    Hirose, Mieko
    Fujita, Shoji
    Abe, Shuji
    Kobayashi, Kunihiko
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (05) : 580 - 582
  • [2] Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort
    Collins, P. W.
    Mathias, M.
    Hanley, J.
    Keeling, D.
    Keenan, R.
    Laffan, M.
    Perry, D.
    Liesner, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (05) : 787 - 794
  • [3] Immune tolerance induction in patients with severe hemophilia A with inhibitors
    Ryu, Ji Eun
    Park, Young Shil
    Yoo, Ki Young
    Lee, Kyoo Duck
    Choi, Yong-Mook
    BLOOD RESEARCH, 2015, 50 (04) : 248 - 253
  • [4] A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice
    Merlin, Simone
    Borroni, Ester
    Bruscaggin, Valentina
    Chuah, Marinee K.
    Arruda, Valder R.
    VandenDriessche, Thierry
    Prat, Maria
    Follenzi, Antonia
    MOLECULAR THERAPY, 2017, 25 (05) : 239 - 239
  • [5] A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice
    Merlin, Simone
    Cannizzo, Elvira Stefania
    Borroni, Ester
    Bruscaggin, Valentina
    Schinco, Piercarla
    Tulalamba, Warut
    Chuah, Marinee K.
    Arruda, Valder R.
    VandenDriessche, Thierry
    Prat, Maria
    Valente, Guido
    Follenzi, Antonia
    MOLECULAR THERAPY, 2017, 25 (08) : 1815 - 1830
  • [6] Immune tolerance induction in children with severe hemophilia A and inhibitor in Poland
    Klukowska, A.
    Laguna, P.
    Dobaczewski, G.
    Janik-Moszant, A.
    Kamienska, E.
    Koltan, A.
    Pietrys, D.
    Waleszkiewicz-Majewska, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1069 - 1070
  • [7] Immune tolerance induction in patients with severe hemophilia A with inhibitors in Korea
    Park, Y. S.
    Yoon, H-J
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 861 - 861
  • [8] Prophylactic treatment and Rituximab subsequent immune tolerance induction therapy to improve inhibitor eradication on resistant ITI in severe hemophilia A patients with inhibitor
    Chen, Yeu-Chin
    Cheng, Shin-Nan
    HAEMOPHILIA, 2016, 22 : 69 - 69
  • [9] 'Low-dose' immune tolerance induction regimens and rituximab in pediatric patients with congenital hemophilia A and B
    Allen, G. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 933 - 933
  • [10] IMMUNE TOLERANCE (IT) INDUCTION IN HEMOPHILIA - EXPERIENCE AT A SINGLE HEMOPHILIA TREATMENT CENTER
    KEY, N
    GREENO, E
    MOERTEL, C
    HEISEL, M
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1030 - 1030
12345